A biomimetic sensor surface to detect anti-β2-glycoprotein-I antibodies as a marker for antiphospholipid syndrome

被引:7
作者
Hilbig, Urs [1 ]
Bleher, Oliver [1 ]
Le Blanc, Alexander [1 ]
Gauglitz, Guenter [1 ]
机构
[1] Univ Tubingen, Inst Phys & Theoret Chem, D-72076 Tubingen, Germany
关键词
Biosensor; Reflectometric interference spectroscopy (RIfS); Optical sensors; Antiphospholipid syndrome (APS); beta(2)-glycoprotein-I; Lipid membranes; DOMAIN I; BETA-2-GLYCOPROTEIN-I; BIOSENSOR; AUTOANTIBODIES; INHIBITION; BINDING;
D O I
10.1007/s00216-012-5831-z
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A biomimetic sensor has been developed, that allows for quantification of autoantibodies related to the antiphospholipid syndrome (APS). Autoantibodies directed against the beta(2)-glycoprotein-I (beta(2)GP-I) are known as the best markers for diagnosis of APS, however, detection of such antibodies is still a challenge. The epitopes of beta(2)GP-I are exposed upon binding to negatively charged membranes. The surface of the sensor chips was therefore modified with such type of membranes, on which beta(2)GP-I molecules were subsequently immobilized as recognition elements. Using the label-free method, reflectometric interference spectroscopy, it was possible to quantify anti-beta(2)GP-I antibodies and to calibrate the sensor chip in buffer. A mild regeneration procedure allows for many consecutive measurements without stripping off the membrane in between.
引用
收藏
页码:713 / 717
页数:5
相关论文
共 24 条
[1]   β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome [J].
Agar, Cetin ;
van Os, Gwendolyn M. A. ;
Morgelin, Matthias ;
Sprenger, Richard R. ;
Marquart, J. Arnoud ;
Urbanus, Rolf T. ;
Derksen, Ronald H. W. M. ;
Meijers, Joost C. M. ;
de Groot, Philip G. .
BLOOD, 2010, 116 (08) :1336-1343
[2]   Pathophysiology of Thrombosis and Potential Targeted Therapies in Antiphospholipid Syndrome [J].
Amengual, Olga ;
Atsumi, Tatsuya ;
Koike, Takao .
CURRENT VASCULAR PHARMACOLOGY, 2011, 9 (05) :606-618
[3]  
BRECHT A, 1992, ANALUSIS, V20, P135
[4]   Twenty-two years of failure to set up undisputed assays to detect patients with the antiphospholipid syndrome [J].
de Groot, Philip G. ;
Derksen, Ronald H. W. M. ;
de Laat, Bas .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (04) :347-355
[5]   Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope [J].
de Laat, Bas ;
van Berkel, Miranda ;
Urbanus, Rolf T. ;
Siregar, Berdien ;
de Groot, Philip G. ;
Gebbink, Martijn F. ;
Maas, Coen .
ARTHRITIS AND RHEUMATISM, 2011, 63 (12) :3960-3968
[6]   Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I [J].
de Laat, Bas ;
de Groot, Philip G. .
CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (01) :70-76
[7]   Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss:: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro [J].
Di Simone, N ;
Raschi, E ;
Testoni, C ;
Castellani, R ;
D'Asta, M ;
Shi, T ;
Krilis, SA ;
Caruso, A ;
Meroni, PL .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (03) :462-467
[8]   Kinetic analysis of the estrogen receptor alpha using RIfS [J].
Fechner, Peter ;
Proell, Florian ;
Albrecht, Christiane ;
Gauglitz, Guenter .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2011, 400 (03) :729-735
[9]   Direct optical detection in bioanalysis: an update [J].
Gauglitz, Guenter .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 398 (06) :2363-2372
[10]   The involvement of β2-glycoprotein I (β2-GPI) in human and murine atherosclerosis [J].
George, J ;
Shoenfeld, Y ;
Harats, D .
JOURNAL OF AUTOIMMUNITY, 1999, 13 (01) :57-60